RAFAEL HOLDINGS, INC. Gain (Loss) on Sale of Interest in Projects
RAFAEL HOLDINGS, INC. (RFL) reported Gain (Loss) on Sale of Interest in Projects of $30.00 thousand for the 12-month period ending 2025-07-31, per its 10-K filed 2025-10-29.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnSaleOfInterestInProjects · last filed 2025-10-29
- RAFAEL HOLDINGS, INC. gain (loss) on sale of interest in projects for the quarter ending 2025-07-31 was $0.00.
- RAFAEL HOLDINGS, INC. gain (loss) on sale of interest in projects for fiscal 2025 was $30.00K.
| Period end | Gain (Loss) on Sale of Interest in Projects 3 month | Gain (Loss) on Sale of Interest in Projects 9 month | Gain (Loss) on Sale of Interest in Projects 12 month |
|---|---|---|---|
| 2025-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | $30.00K 10-K · filed 2025-10-29 | |
| 2025-04-30 | $30.00K 10-Q · filed 2025-06-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |